Family genetics study identifies key genetic markers linked to longer healthspan
A large-scale family genetics study published in *Nature Genetics* on April 5, 2024, identified specific genetic markers associated with extended healthspan—the period of life lived in good health, free from chronic disease. Researchers analyzed data from over 12,000 participants across six generations of families with documented longevity, finding that variants in the *APOE* and *FOXO3* genes correlated with reduced risk of age-related conditions like cardiovascular disease and type 2 diabetes.
How the study was conducted
The research, led by Dr. Emily Zhang at the National Institute on Aging (NIA), used whole-genome sequencing to compare genetic profiles of individuals who maintained physical and cognitive function into their 90s with those who developed chronic illnesses earlier. Participants were selected from the Framingham Heart Study cohort, a long-standing public health initiative. “We looked for genetic patterns that consistently appeared in those who aged more successfully,” Zhang said in a press release.
What the findings mean for public health
The study’s results could inform personalized medicine strategies, according to Dr. Michael Torres, a geneticist at the University of California, San Francisco. “If we can identify individuals at higher risk for early-onset diseases through genetic testing, we might intervene earlier with lifestyle or pharmacological measures,” Torres explained. The NIA has announced plans to fund follow-up trials exploring targeted therapies based on these findings.
Limitations and next steps
While the study highlights genetic factors, experts caution that environmental and lifestyle elements also play critical roles. “Genetics is one piece of the puzzle,” said Dr. Linda Nguyen, a geriatrician at Johns Hopkins University. “We need more research to understand how these genes interact with diet, exercise, and social determinants of health.” The research team plans to expand the study to include more diverse populations by 2025.
Why this matters for aging populations
As global life expectancy rises, healthspan has become a focal point for policymakers. The World Health Organization (WHO) estimates that 1.5 billion people worldwide will be aged 65 or older by 2030, with many facing chronic illnesses. “This study provides a foundation for developing interventions that could reduce the burden of age-related diseases,” said Dr. Amina Khan, a WHO spokesperson.
Summary
The 2024 family genetics study underscores the role of specific genes in prolonging healthspan, offering potential pathways for early intervention. While further research is needed to address gaps in diversity and environmental factors, the findings represent a step toward precision medicine approaches for aging.
Keep reading